Interventional Cardiology

Filter

Transcatheter heart valve

Next-Gen Transcatheter Heart Valve Sets New Standard

October 2025

DurAVR, a transcatheter heart valve, achieves excellent hydrodynamics across TAVI scenarios. Read more to discover its clinical potential.

How CAD Type Influences Left Ventricular Ejection Fraction Change After PCI

LVEF recovery post-PCI differs by CAD presentation, significantly impacting long-term prognosis, particularly in STEMI patients.

Landmark Trial Confirms Superiority of TAVI-PCI in Severe Aortic Stenosis and Coronary Disease

PCI plus TAVI offers superior outcomes over SAVR plus CABG for severe aortic stenosis and complex CAD.

Promising Results for K-Clip System in Severe Functional Tricuspid Regurgitation

K-Clip shows high success rates, improved quality of life, and sustained TR reduction in severe tricuspid regurgitation patients.

3D Echocardiography with Vena Contracta Area Predicts Survival After Mitral TEER

3D-Vena Contracta Area (VCA) predicts one-year survival after mitral TEER, guiding better clinical decisions and outcomes.

Clopidogrel Outperforms Aspirin for Post-PCI Therapy

Clopidogrel reduces thrombotic and bleeding risks over aspirin after PCI, effective regardless of bleeding risk or complexity.

Combining T-TEER with OMT for Severe Tricuspid Regurgitation

T-TEER improves patient outcomes and quality of life in severe tricuspid regurgitation compared to medical therapy alone.

Bicaval TricValve Tricuspid Regurgitation: Late-Breaking PCR London Valves 2024

Bicaval TricValve shows safety, improves symptoms, and reduces hospitalisations in patients with severe tricuspid regurgitation.

MiCLASP Study Two-Year Outcomes: Late-Breaking PCR London Valves 2024

The MiCLASP study highlights the PASCAL system’s sustained safety and effectiveness in reducing mitral regurgitation at two years.

Loading posts...

« Previous 1 … 5 6 7 8 9 … 13 Next »